Back to companies

Lonza Group Ltd: Overview

Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Lonza Group Ltd (Lonza) is a contract manufacturing and development solutions company. It offers services including commercial mammalian and microbial manufacturing, clinical development, and manufacturing. It also offers high potential active pharmaceutical ingredients, cell and gene therapy capabilities, advanced intermediates, oral drug product development services, cell-culture modeling, genome editing, endotoxin products, and research media and testing products. Lonza provides solutions for health and well-being, microbial and hygiene control, and composites and material protection. Lonza serves biotechnology, pharmaceutical, academic, and government research industries; manufacturers of health and consumer products; formulators and service companies. The company operates manufacturing and R&D facilities in Asia, Europe, and the Americas. Lonza is headquartered in Basel, Switzerland.

Headquarters Switzerland

Address Muenchensteinerstrasse 38, Basel, 4002


Telephone 41 61 3168111

No of Employees 16,218

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange LONN (SWF)

Revenue (2021) $5.9B 20% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX 238.8% (2021 vs 2020)

Market Cap* $40.1B

Net Profit Margin (2021) XXX 182.3% (2021 vs 2020)

* As of and is in US$

Explore premium data & analytics

40+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

30+

Clinical Trials

Determine Lonza Group Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Lonza Group Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Lonza Group Ltd’s relevant decision makers and contact details.

20+

Catalyst Calendar

Proactively evaluate Lonza Group Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services Brands
BioResearch Solutions: Development Technologies Aldo
Stem Cells GS Xceed Gene Expression System Biovert
Primary Cells and Media XS Technologies for Microbial Expression Black Willow Extract
XXX XXX XXX
XXX XXX XXX
XXX XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Corporate Changes/Expansions In May, the company expanded its Capsugel offering with a titanium dioxide-free (TiO2-free) white hard gelatin capsule, fulfilling the evolving demand of its customers to meet new titanium dioxide-free requirements for foods in the European Union.
2022 Corporate Changes/Expansions In May, the company and Kodiak Sciences opened a new bioconjugation facility in Visp, Switzerland.
2022 Contracts/Agreements In May, the company and ALSA Ventures collaborated to provide development and manufacturing services for Biotech Firms.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Lonza Group Ltd Royal DSM NV Dottikon ES Holding AG Mabuhay Vinyl Corp ADC Therapeutics SA
Headquarters Switzerland Netherlands Switzerland Philippines Switzerland
City Basel Heerlen Dottikon Makati Epalinges
No. of Employees 16,218 21,358 658 153 312
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Net Income Growth

Image for loader
Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Albert M. Baehny Chairman Executive Board 2018 -
Pierre Alain Ruffieux, Ph.D. Chief Executive Officer Senior Management 2020 -
Philippe Deecke Chief Financial Officer Senior Management 2021 -
Caroline Barth Chief Human Resources Officer Senior Management 2020 -
Christoph Mader Vice Chairman Executive Board 2020 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer